Publication Date
In 2025 | 0 |
Since 2024 | 1 |
Since 2021 (last 5 years) | 1 |
Since 2016 (last 10 years) | 4 |
Since 2006 (last 20 years) | 7 |
Descriptor
Adults | 6 |
Autism | 5 |
Pervasive Developmental… | 5 |
Symptoms (Individual… | 5 |
Behavior Problems | 4 |
Drug Therapy | 4 |
Aggression | 3 |
Check Lists | 3 |
Outcomes of Treatment | 3 |
Adolescents | 2 |
Behavior Disorders | 2 |
More ▼ |
Source
Journal of Autism and… | 8 |
Author
Andrew Pickles | 1 |
Baud, M. A. | 1 |
Benabides, Bobbie | 1 |
Carminati, G. Galli | 1 |
Chez, Michael | 1 |
Emily Simonoff | 1 |
Fleming, Kandace K. | 1 |
Fung, Lawrence K. | 1 |
Gerber, F. | 1 |
Gillian Baird | 1 |
Giroud, M. | 1 |
More ▼ |
Publication Type
Journal Articles | 8 |
Reports - Research | 7 |
Reports - Evaluative | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
Aberrant Behavior Checklist | 8 |
Strengths and Difficulties… | 1 |
What Works Clearinghouse Rating
Melanie Palmer; Zhaonan Fang; Matthew J. Hollocks; Tony Charman; Andrew Pickles; Gillian Baird; Emily Simonoff – Journal of Autism and Developmental Disorders, 2024
Objective: Attention Deficit Hyperactivity Disorder (ADHD) is a common co-occurring condition in autistic individuals. ADHD is sometimes first recognised in young adulthood because ADHD symptoms may be misattributed to autism due to superficial overlap in presentation and diagnostic overshadowing. It should be investigated whether ADHD…
Descriptors: Screening Tests, Attention Deficit Hyperactivity Disorder, Young Adults, Autism Spectrum Disorders
Chez, Michael; Kile, Shawn; Lepage, Christopher; Parise, Carol; Benabides, Bobbie; Hankins, Andrea – Journal of Autism and Developmental Disorders, 2020
Prior studies have demonstrated successful irritability treatment using dopaminergic antagonists in autistic patients. The purpose of this pilot study was to assess the effect of dextromethorphan/quinidine (DM/Q) in autistic adults (18-60 years of age). This was a randomized, blinded, crossover, study of 14 patients randomized to DM/Q or a placebo…
Descriptors: Outcomes of Treatment, Randomized Controlled Trials, Pilot Projects, Drug Therapy
Taylor, Briana J.; Sanders, Kevin B.; Kyle, Marie; Pedersen, Kahsi A.; Veenstra-Vanderweele, Jeremy; Siegel, Matthew – Journal of Autism and Developmental Disorders, 2019
Psychiatric hospitalization of children with autism spectrum disorder (ASD) is common, but there is little comparative information available on different psychiatric hospital treatment models. Children with ASD ages 4-20 were enrolled upon admission to either a specialized (N = 53) or a general child psychiatric unit (N = 27). Caregivers completed…
Descriptors: Psychiatric Hospitals, Patients, Children, Adolescents
Lewis, Alan S.; van Schalkwyk, Gerrit Ian; Lopez, Mayra Ortiz; Volkmar, Fred R.; Picciotto, Marina R.; Sukhodolsky, Denis G. – Journal of Autism and Developmental Disorders, 2018
Nicotinic acetylcholine receptors (nAChRs), particularly the a7 nAChR, are implicated in the pathophysiology of both autism spectrum disorder (ASD) and aggressive behavior. We explored the feasibility, tolerability, and preliminary efficacy of targeting nAChRs using transdermal nicotine to reduce aggressive symptoms in adults with ASD. Eight…
Descriptors: Aggression, Adults, Stimulants, Pervasive Developmental Disorders
Fung, Lawrence K.; Libove, Robin A.; Phillips, Jennifer; Haddad, Francois; Hardan, Antonio Y. – Journal of Autism and Developmental Disorders, 2014
The objective of this study was to assess the tolerability and efficacy of pregnenolone in reducing irritability in adults with autism spectrum disorder (ASD). This was a pilot, open-label, 12-week trial that included twelve subjects with a mean age of 22.5 ± 5.8 years. Two participants dropped out of the study due to reasons unrelated to adverse…
Descriptors: Adults, Pervasive Developmental Disorders, Autism, Drug Therapy
Gerber, F.; Baud, M. A.; Giroud, M.; Carminati, G. Galli – Journal of Autism and Developmental Disorders, 2008
The purpose of this study was to observe quality of life (QoL) and global evolution of persons with Pervasive Developmental Disorders (PDD) in three different groups. Individualized programs for PDD were compared to traditional programs for intellectual disabilities. Behavioural disorders were repeatedly evaluated using the Aberrant Behaviour…
Descriptors: Quality of Life, Adults, Pervasive Developmental Disorders, Mental Retardation
Hellings, Jessica A.; Zarcone, Jennifer R.; Reese, R. Matthew; Valdovinos, Maria G.; Marquis, Janet G.; Fleming, Kandace K.; Schroeder, Stephen R. – Journal of Autism and Developmental Disorders, 2006
Risperidone has shown safety and efficacy for aggressive and destructive behaviors in short-term studies. This longer-duration study includes a broad sample. Forty subjects, aged 8-56 years (mean=22), all with mental retardation and 36 with autism spectrum disorders participated in this 22-week crossover study, with 24 weeks of open maintenance…
Descriptors: Drug Therapy, Mental Retardation, Pervasive Developmental Disorders, Children
Lopez, Brian R.; Lincoln, Alan J.; Ozonoff, Sally; Lai, Zona – Journal of Autism and Developmental Disorders, 2005
The executive function theory was utilized to examine the relationship between cognitive process and the restricted, repetitive symptoms of Autistic Disorder (AD). Seventeen adults with AD were compared to 17 nonautistic controls on a new executive function battery (Delis-Kaplin Executive Function Scales). Restricted, repetitive symptoms were…
Descriptors: Memory, Rating Scales, Autism, Cognitive Processes